M. Mukai, T. Tajima, H. Nakasaki, Shinkichi Sato, K. Ogoshi, H. Makuuchi
tlooto Summary
Among 370 patients who underwent radical resection of primary colorectal cancer over a 17-year period, 167 had stage II-Dukes' B cancer, and 11 had rare histological types other than typical differentiated adenocarcinoma.
Abstract
Among 370 patients who underwent radical resection of primary colorectal cancer over a 17-year period, 167 had stage II-Dukes' B cancer. After excluding 10 patients treated with intravenous drugs other than 5-FU or hepatic arterial injection and 11 patients with rare histological types other than typical differentiated adenocarcinoma, the Address correspondence to: Masaya Mukai, M.D., Ph.D. Tokai University Oiso Hospital, Department of Surgery, Gakyou 21-1, Oiso, Kanagawa, 259-0198, Japan. FAX: +81-463-72-2256; TEL: +81-463-72-3211 (Ex. 235); E-mail: colorectalmasaya@yahoo.co.jp. Received 04/15/03; accepted 05/14/03.
Citation format
MUKAI, M., et al. EFFICACY OF POSTOPERATIVE ADJUVANT ORAL IMMUNOCHEMOTHERAPY IN PATIENTS WITH DUKES'C COLORECTAL CANCER. Annals of Cancer Research and Therapy, 2003, 11: 215–229.